Strategic Partnerships Rigshospitalet actively pursues international collaborations and joint research initiatives, evidenced by partnerships like Cessatech in 2026 and the Skåne University Hospital collaboration, plus the 2023 Surgical Safety Technologies alliance. This signals openness to co-development, sponsored trials, and cross-border procurement opportunities for medtech and pharma partners.

Innovative Diagnostics The ear-EEG diagnostic project with Aarhus University and T&W Engineering demonstrates readiness to adopt cutting-edge diagnostics hardware and software. This creates opportunities to sell neurodiagnostic devices, cloud analytics platforms, AI-enabled decision support, and integration with existing hospital IT systems.

Pharma and Nuclear Active engagement in radiopharmaceuticals and drug formulations, including Astatine-211 supply agreements and intravenous melatonin collaborations, highlights demand for radiochemicals, compliant supply chains, regulatory-friendly logistics, and clinical-trial support from biotech and pharma partners.

Tech Stack Fit Rigshospitalet's tech stack includes SAP, Siemens, OneTrust and analytics tools, indicating a strong fit for enterprise IT, privacy and compliance solutions, data analytics dashboards, and seamless ERP/EHR integrations with vendors offering digital transformation services.

Global Reach Serving Denmark, the Faroe Islands and Greenland with substantial research funding (Novo Nordisk Foundation) and cross-border collaborations positions the hospital as a scalable market for cross-border healthcare solutions, telemedicine, and EU-backed research partnerships.